{
    "2021-09-04": [
        [
            {
                "time": "",
                "original_text": "全球首款！新冠肺炎“特效药”获批临床试验",
                "features": {
                    "keywords": [
                        "全球首款",
                        "新冠肺炎",
                        "特效药",
                        "获批",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物(600161)：业绩保持稳定增长 持续获批新浆站 浆源获取能力得到验证",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "600161",
                        "业绩",
                        "稳定增长",
                        "获批",
                        "新浆站",
                        "浆源获取能力"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}